C 24 H 60 AgClN 12 O 6 P4, tetragonal,
was left to crystallize. Colourless crystals suitable for X-ray diffraction were obtained in 85.2% yield (0.488 g).
Experimental details
The aliphatic H atoms were placed in geometrically idealized positions and constrained to ride on their parent atoms with C-H = 0.99 Å and U iso (H) = 1.2 Ueq(C). H atoms at the water molecules were refined isotropically.
Comment
The complex obtained is a water soluble four-coordinate silver complex with chloride counterions. The known cytotoxicity and cell malignity of silver and silver nanoparticles suggests that this compound may be a candidate for anticancer development [6] . Many variants of silver complexes have been developed and proved to demonstrate excellent antibacterial and antifungal properties [7] [8] [9] [10] . 1,3,5-Triaza-7-phosphaadamantane (PTA) was selected as the ligand for this complex due to its ability to solubilize transition metal complexes [11] , allowing for the introduction into the blood circulatory system as aqueous solubility is a key parameter to help determine rate and extent of drug absorption [12] . Adamantane complexes have also seen considerable success in aqueous phase and biphasic homogenous catalysis; 1,3,5-triaza-7-phosphaadamantane complexes of rhodium and ruthenium has been found to be catalytically active for the conversion of aldehydes to alcohols [13, 14] .
In the title compound the Ag atom is in a four-coordinate environment and adopts a distorted tetrahedral geometry, with the Ag and Cl atoms on special positions. As the complex crystallizes with high symmetry the Ag-P bond lengths are identical: 2.4676(4) Å. The P-Ag-P angles of the title compound are either 108.67(1)°or 111.08(1)°and the effective cone angle [15] is 108.53(1)°. The crystal structure is stabilized by an array of weak C-H···Cl and strong O-H···N hydrogen bonds. The title structure is structurally closely related to a Au(I) complex [16] .
